chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: 606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. The vial was placed in the refrigerator on 18-Nov-2021.Vial did not undergo any temperature excursion.  No adverse event was reported. No treatment medications were reported.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: vaccine was kept in refrigerator on 29 Oct 2021 and administered on 02 Nov 2021; 606 doses were given after expiration date / vaccine was kept in refrigerator on 29 Oct 2021 and expired on 13 Oct 2021; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date / vaccine was kept in refrigerator on 29 Oct 2021 and expired on 13 Oct 2021) and PRODUCT STORAGE ERROR (vaccine was kept in refrigerator on 29 Oct 2021 and administered on 02 Nov 2021) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date / vaccine was kept in refrigerator on 29 Oct 2021 and expired on 13 Oct 2021). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vaccine was kept in refrigerator on 29 Oct 2021 and administered on 02 Nov 2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date / vaccine was kept in refrigerator on 29 Oct 2021 and expired on 13 Oct 2021) and PRODUCT STORAGE ERROR (vaccine was kept in refrigerator on 29 Oct 2021 and administered on 02 Nov 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information provided. No treatment medication information provided. No temperature excursion of the product reported. No adverse event experienced by the patient.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Expired vaccine is stored in refrigerator on 31-Oct-2021 and then administered on 05-Nov-2021; doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date) and PRODUCT STORAGE ERROR (Expired vaccine is stored in refrigerator on 31-Oct-2021 and then administered on 05-Nov-2021) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Expired vaccine is stored in refrigerator on 31-Oct-2021 and then administered on 05-Nov-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date) and PRODUCT STORAGE ERROR (Expired vaccine is stored in refrigerator on 31-Oct-2021 and then administered on 05-Nov-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  It was reported that there was a confusion between the expiration date printed in the carton and the expiration date when the QR code was scanned. No adverse events were reported. Vial did not undergo any temperature excursion. Vial was placed in refrigerator on 31-Oct-2021.  No treatment medications were reported.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Vaccine was stored on refrigerator on 04-Nov-2021 and then administered on 09-NOV-2021; 606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine was stored on refrigerator on 04-Nov-2021 and then administered on 09-NOV-2021) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Nov-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored on refrigerator on 04-Nov-2021 and then administered on 09-NOV-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine was stored on refrigerator on 04-Nov-2021 and then administered on 09-NOV-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication reported. On 04-Nov-2021, the vial was placed in the refrigerator. The vial did not have any temperature excursion and the patient had no adverse event. No Treatment medication reported.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Vaccine expired on 13-OCT-2021 and placed in refrigerator on 04-Nov-2021; 606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine expired on 13-OCT-2021 and placed in refrigerator on 04-Nov-2021) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Nov-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 13-OCT-2021 and placed in refrigerator on 04-Nov-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine expired on 13-OCT-2021 and placed in refrigerator on 04-Nov-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The vial did not had any temperature excursion and the patient had no adverse event.    No concomitant medication information was provided. No treatment medication information was provided.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Vaccine expired on 13 Oct 2021 and placed in refrigerator on 04 Nov 2021; 606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine expired on 13 Oct 2021 and placed in refrigerator on 04 Nov 2021) and EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 13 Oct 2021 and placed in refrigerator on 04 Nov 2021). At the time of the report, PRODUCT STORAGE ERROR (Vaccine expired on 13 Oct 2021 and placed in refrigerator on 04 Nov 2021) and EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. Vaccine was placed in refrigerator on 04-Nov-2021. Vial did not undergo any temperature excursion. No adverse events were reported. No treatment medications were reported.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: 606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.  On 18-Nov-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was not reported.  Vial was place in refrigerator on 01-Mar-2022 and vial did not undergo any temperature excursion.  It was reported that patient did not experience any adverse event.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Vaccine was stored after expiration date in the refrigerator; 606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine was stored after expiration date in the refrigerator) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored after expiration date in the refrigerator). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine was stored after expiration date in the refrigerator) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported.  Date vial placed in refrigerator was 04-Nov-2022. The vial did not underwent temperature excursion. Patient did not experience any adverse event.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Expired vaccine is stored and then administered; doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date) and PRODUCT STORAGE ERROR (Expired vaccine is stored and then administered) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Expired vaccine is stored and then administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date) and PRODUCT STORAGE ERROR (Expired vaccine is stored and then administered) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant drugs were not reported. No temperature excursion and no adverse event was reported. Vaccine was placed in refrigerator on 22-Sep-2021. Treatment details were not given.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Vaccine was kept in refrigerator on 08 Nov 2021 and administered on 08 Nov 2021; 606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine was kept in refrigerator on 08 Nov 2021 and administered on 08 Nov 2021) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was kept in refrigerator on 08 Nov 2021 and administered on 08 Nov 2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine was kept in refrigerator on 08 Nov 2021 and administered on 08 Nov 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.  HCP said that 606 doses were given after expiration date. HCP said that there was a confusion between the expiration date printed in the carton and the expiration date when the QR code was scanned.  On 08-Nov-2021, the vial was stored in the refrigerator. The vial did not undergo any temperature excursions and had no adverse event.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Product storage error; Doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses were given after expiration date) and PRODUCT STORAGE ERROR (Product storage error) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Nov-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Product storage error). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses were given after expiration date) and PRODUCT STORAGE ERROR (Product storage error) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  Date the vial was initially stored in the refrigerator was 04-Nov-2021. There was no temperature excursion. The reporter reported that that there was a confusion between the expiration date printed in the carton and the expiration date when the QR code was scanned.  The patient did not experience any adverse event.  No treatment information was provided by the reporter.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Vaccine stored in refrigerator 17-Nov-2021, expired product 03-Oct-2021, administered date on 23-Nov-2021; 606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine stored in refrigerator 17-Nov-2021, expired product 03-Oct-2021, administered date on 23-Nov-2021) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine stored in refrigerator 17-Nov-2021, expired product 03-Oct-2021, administered date on 23-Nov-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine stored in refrigerator 17-Nov-2021, expired product 03-Oct-2021, administered date on 23-Nov-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The date of vial placed in refrigerator was on 17-NOV-2021 and vaccine did not undergone any temperature excursion. Patient did not experience any adverse event. No concomitant were reported. No treatment were reported.
Age: 58.0
Sex: M
Vaccine: VARZOS
Symptoms: Pain, Procedural pain, Wrist surgery
Clinical narrative: Extreme post-operative pain.  Surgery occurred  five days prior, orthopedic repair of wrist on same arm as vaccine.  Pain increased to 3-5 x worse than any point post operative.  Pain began to subside about 24 hours after vaccination.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Flushing, Hyperhidrosis, Injection site erythema, Seizure like phenomena
Clinical narrative: Site: Redness at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: see below-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Shakiness-Severe, Additional Details: Patient was shaking as if having a seizur no history, lasted roughly 10 seconds, snapped out of it, then just dizzy, sweaty, light headed.  Said he has severe anxiety for which he is on disability for the last 10 years
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Syncope, Tremor, Unresponsive to stimuli
Clinical narrative: Site: Redness at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: see below-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Shakiness-Severe, Additional Details: Patient was shaking as if having a seizur no history, lasted roughly 10 seconds, snapped out of it, then just dizzy, sweaty, light headed.  Said he has severe anxiety for which he is on disability for the last 10 years
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Error: Incorrect Reconstitution.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Syncope, Tremor, Unresponsive to stimuli
Clinical narrative: Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Medium, Systemic: Shakiness-Medium, Additional Details: Patient had Pfizer 1st dose administered in left deltoid on 03/08/2022 at 7:10pm.  Shortly after patient experience syncope for <10 seconds.  Was alert and oriented, normal blood pressure.  Monitored for 30 minutes, and two blood pressure checks were normal.  Follow up with patient on 03/09/2022 and patient reported no further issues.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Allergy test, Angiogram, Autonomic nervous system imbalance, Biopsy skin, Colonoscopy
Clinical narrative: Numbness and tingling of hands and feet, autonomic dysfunction, facial flushing, diagnosed with Small Fiber Neuropathy in Jan 2022.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram thorax, Electrocardiogram, Endoscopy, Flushing, Hypoaesthesia
Clinical narrative: Numbness and tingling of hands and feet, autonomic dysfunction, facial flushing, diagnosed with Small Fiber Neuropathy in Jan 2022.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Magnetic resonance imaging head, Magnetic resonance imaging heart, Paraesthesia, Positron emission tomogram, Small fibre neuropathy
Clinical narrative: Numbness and tingling of hands and feet, autonomic dysfunction, facial flushing, diagnosed with Small Fiber Neuropathy in Jan 2022.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Tryptase
Clinical narrative: Numbness and tingling of hands and feet, autonomic dysfunction, facial flushing, diagnosed with Small Fiber Neuropathy in Jan 2022.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site bruising
Clinical narrative: Site: Bruising at Injection Site-Medium
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Covid-19 vaccine breakthrough case. Dose 1 Moderna 3/13/21 lot #002B21A. Dose 2 Moderna 4/10/21 lot #025B21A.
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, COVID-19, Chest X-ray abnormal, Condition aggravated, Decreased appetite
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 02/09/2021.  83 y/o with PMHX Afib, asthma, DVT/IVC filter, HTN, HLD, Quadriplegia, COPD, Complex UTI, Kidney stones, nephrostomy tubes, malignant melanoma presents to ED via EMS due to AMS.  Pt's daughter states this occurs when pt has a UTI.  Pt admits to weakness, decreased appetitie, SOB and heart racing for last few days.  Found to have UTI and kidney stones.  Covid19 test negative on 02/21/2022 and 02/28/2022.  Pt retested on 03/09/2022 as pre procedure order and is now positive.  O2sat 1L-99%, afebrile and CXR with patchy interstitial opacities.  On IV ABX.
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Lung opacity, Mental status changes, Nephrolithiasis, Palpitations
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 02/09/2021.  83 y/o with PMHX Afib, asthma, DVT/IVC filter, HTN, HLD, Quadriplegia, COPD, Complex UTI, Kidney stones, nephrostomy tubes, malignant melanoma presents to ED via EMS due to AMS.  Pt's daughter states this occurs when pt has a UTI.  Pt admits to weakness, decreased appetitie, SOB and heart racing for last few days.  Found to have UTI and kidney stones.  Covid19 test negative on 02/21/2022 and 02/28/2022.  Pt retested on 03/09/2022 as pre procedure order and is now positive.  O2sat 1L-99%, afebrile and CXR with patchy interstitial opacities.  On IV ABX.
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Urinary tract infection, Vaccine breakthrough infection
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 02/09/2021.  83 y/o with PMHX Afib, asthma, DVT/IVC filter, HTN, HLD, Quadriplegia, COPD, Complex UTI, Kidney stones, nephrostomy tubes, malignant melanoma presents to ED via EMS due to AMS.  Pt's daughter states this occurs when pt has a UTI.  Pt admits to weakness, decreased appetitie, SOB and heart racing for last few days.  Found to have UTI and kidney stones.  Covid19 test negative on 02/21/2022 and 02/28/2022.  Pt retested on 03/09/2022 as pre procedure order and is now positive.  O2sat 1L-99%, afebrile and CXR with patchy interstitial opacities.  On IV ABX.
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: A temperature excursion happened with the vaccine that this patient received. The vial was stored in the freezer past the 2 weeks of provided stability info.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: A vaccine was given that experienced a temperature excursion. The affected vial was in the freezer past the 2 weeks of stability info provided by the CDC.
Age: 56.0
Sex: F
Vaccine: VARZOS
Symptoms: Pruritus, Pyrexia, Vaccination site erythema, Vaccination site swelling
Clinical narrative: Fever, redness at the vax site, swelling at the vax site, itching
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: A vaccine was given that experienced a temperature excursion. The affected vial was in the freezer past the 2 weeks of stability info provided by the CDC.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: COVID-19 resulting in inpatient hospitalization of a vaccinated patient.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Influenza A virus test negative, Influenza B virus test
Clinical narrative: Breathing Problem      states pt had DIB 2 hours pta. Initially 76% on RA./ FD administered 125 mg Solumedrol and 1x breathing tx en route, were able to get SPO2 up to 90%.     HPI    Patient is a 74-year-old male with past medical history of A. fib, COPD, GI bleed, hypertension, CAD with complete occlusion of RCA, and who presents to the ED for shortness of breath that started last night. Acutely worsened this morning. Patient arrived via EMS from home. On EMS arrival, patient was found to be 70% on room air. He was placed on CPAP with improvement to 90%. Wife states that patient had started a cough last night. Patient is currently still smoking.   Review of Systems  Constitutional: Negative for chills and fever.  HENT: Negative for congestion, rhinorrhea and sore throat.   Eyes: Negative for pain and visual disturbance.  Respiratory: Positive for cough and shortness of breath.   Cardiovascular: Negative for chest pain and palpitations.  Gastrointestinal: Negative for abdominal pain, constipation, diarrhea, nausea and vomiting.  Genitourinary: Negative for dysuria, flank pain and hematuria.  Musculoskeletal: Negative for back pain and neck pain.  Skin: Negative for rash and wound.  Neurological: Negative for dizziness, syncope, light-headedness and headaches.  Psychiatric/Behavioral: Negative for confusion and hallucinations.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Positive airway pressure therapy, Respiratory syncytial virus test negative, SARS-CoV-2 test positive
Clinical narrative: Breathing Problem      states pt had DIB 2 hours pta. Initially 76% on RA./ FD administered 125 mg Solumedrol and 1x breathing tx en route, were able to get SPO2 up to 90%.     HPI    Patient is a 74-year-old male with past medical history of A. fib, COPD, GI bleed, hypertension, CAD with complete occlusion of RCA, and who presents to the ED for shortness of breath that started last night. Acutely worsened this morning. Patient arrived via EMS from home. On EMS arrival, patient was found to be 70% on room air. He was placed on CPAP with improvement to 90%. Wife states that patient had started a cough last night. Patient is currently still smoking.   Review of Systems  Constitutional: Negative for chills and fever.  HENT: Negative for congestion, rhinorrhea and sore throat.   Eyes: Negative for pain and visual disturbance.  Respiratory: Positive for cough and shortness of breath.   Cardiovascular: Negative for chest pain and palpitations.  Gastrointestinal: Negative for abdominal pain, constipation, diarrhea, nausea and vomiting.  Genitourinary: Negative for dysuria, flank pain and hematuria.  Musculoskeletal: Negative for back pain and neck pain.  Skin: Negative for rash and wound.  Neurological: Negative for dizziness, syncope, light-headedness and headaches.  Psychiatric/Behavioral: Negative for confusion and hallucinations.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products, No adverse event
Clinical narrative: Pt. present for 2nd COVID vaccine Moderna, and requested Pfizer. Contract nurse, RN gave Pfizer for 2nd dose. Pt. remained in clinic for 20 minutes, notified of vaccine error, pt. without adverse effects.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: A vaccine was given that experienced a temperature excursion. The affected vial was in the freezer past the 2 weeks of stability from info provided by the CDC.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: A vaccine was given that experienced a temperature excursion. The affected vial was in the freezer past the 2 weeks of stability info provided by the CDC.
Age: 91.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19
Clinical narrative: COVID-19 resulting in inpatient hospitalization" of a vaccinated patient
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: A vaccine was given that experienced a temperature excursion. The affected vial was in the freezer past the 2 weeks of stability info provided by the CDC.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asymptomatic COVID-19, Atelectasis, Chest X-ray abnormal, Colectomy, Dyspnoea
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 02/12/2022.  78 y/o with PMHX Afib, CKD, SIADH, Pulmonary HTN, newly diagnosed Colon Cancer, Anemia and GIB admitted to hospital for Right Colectomy.  Pre procedure Covid test Positive, pt asymptomatic.  Surgery performed on 03/07/2022.  Pt remains afebrile but began to have SOB requiring O2 at 5LNC-92%  on 03/09/2022.  Pt currently on O2 at 2L NC sat 100%.   CXR with small bilat pleural effusions and opacification of lower lobes likely consolidation or atelectasis.  No current covid treatment.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Lung consolidation, Lung opacity, Pleural effusion, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 02/12/2022.  78 y/o with PMHX Afib, CKD, SIADH, Pulmonary HTN, newly diagnosed Colon Cancer, Anemia and GIB admitted to hospital for Right Colectomy.  Pre procedure Covid test Positive, pt asymptomatic.  Surgery performed on 03/07/2022.  Pt remains afebrile but began to have SOB requiring O2 at 5LNC-92%  on 03/09/2022.  Pt currently on O2 at 2L NC sat 100%.   CXR with small bilat pleural effusions and opacification of lower lobes likely consolidation or atelectasis.  No current covid treatment.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Dizziness, Dysmenorrhoea, Fatigue, Headache
Clinical narrative: It was 2 days prior taking the vaccine I finished my menstrual cycle. And on 2/15 the day after I got the my first vaccine my menstrual cycle started again with heavy bleeding, blood clots, cramps, headache. This went on for 10 days. Then changed to spotting for another week.  I took my second shot of moderna on 3/4 at this time I was done with my period and one day later my menstrual cycle started again with heavy flow, blood clots, cramps, headache, dizziness, fatigue, chills, fever
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heavy menstrual bleeding, Interchange of vaccine products, Intermenstrual bleeding, Menstruation irregular, Pyrexia
Clinical narrative: It was 2 days prior taking the vaccine I finished my menstrual cycle. And on 2/15 the day after I got the my first vaccine my menstrual cycle started again with heavy bleeding, blood clots, cramps, headache. This went on for 10 days. Then changed to spotting for another week.  I took my second shot of moderna on 3/4 at this time I was done with my period and one day later my menstrual cycle started again with heavy flow, blood clots, cramps, headache, dizziness, fatigue, chills, fever
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19
Clinical narrative: COVID-19 resulting in inpatient hospitalization" of a vaccinated patient
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash, Rash papular, Rash pruritic, Skin lesion
Clinical narrative: Since 3 December he has complained of recurrent episodes of generalized itching and rashes described as raised, red, itchy whelts which can occur anywhere on his body, especially at sites of pressure or where his skin is scraped or scratched. Lesions last less than 24 hours, affects his palms and soles, and resolve without post-inflammatory changes. Symptoms led him to present to the ER on 4 December where he was treated with oral corticosteroids; he subsequently received three additional courses of IM and oral corticosteroids with only limited benefit. He denies laryngeal, pulmonary, GI, neurologic, and cardiovascular symptoms with these episodes. Episodes not associated with heat, exercise, sweating, cold, foods, medications, NSAIDs, IV contrast, latex exposure, infections, or insect bites/stings. He received his Moderna COVID-19 vaccine booster dose on 19 November, 14 days prior to onset of symptoms. He has used oral antihistamines with minimal benefit. He denies constitutional symptoms. UCT score today is 5 (1, 1, 0, 1, 1, 1, 0, 0). No history of adverse reactions to prior vaccines.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Since 3 December he has complained of recurrent episodes of generalized itching and rashes described as raised, red, itchy whelts which can occur anywhere on his body, especially at sites of pressure or where his skin is scraped or scratched. Lesions last less than 24 hours, affects his palms and soles, and resolve without post-inflammatory changes. Symptoms led him to present to the ER on 4 December where he was treated with oral corticosteroids; he subsequently received three additional courses of IM and oral corticosteroids with only limited benefit. He denies laryngeal, pulmonary, GI, neurologic, and cardiovascular symptoms with these episodes. Episodes not associated with heat, exercise, sweating, cold, foods, medications, NSAIDs, IV contrast, latex exposure, infections, or insect bites/stings. He received his Moderna COVID-19 vaccine booster dose on 19 November, 14 days prior to onset of symptoms. He has used oral antihistamines with minimal benefit. He denies constitutional symptoms. UCT score today is 5 (1, 1, 0, 1, 1, 1, 0, 0). No history of adverse reactions to prior vaccines.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products, No adverse event, Product administration error
Clinical narrative: The patient didn't have any adverse event but he received a administration vaccine error. His first Covid vaccine was Moderna and the second one he received was Pfizer. He was vaccinated at his home by the hospital staff. The nurse that administered the vaccine gave an orientation to the patient that it was an error but he didn't have to repeat the dose and that in five months from the actual date he should receive a booster vaccine of his preference Moderna or Pfizer.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: COVID-19 resulting in inpatient hospitalization" of a vaccinated patient
Age: 69.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: COVID-19, Chills, Diarrhoea, Feeling abnormal, Hyperhidrosis
Clinical narrative: The day of vaccine, my left arm was very sore and had a hard time sleeping. I could not lift my arm. I started to chill and finally went to sleep and woke up in a sweat. I woke up the next morning not feeling well. Then I went back to bed and felt feverish. My body had aches and pains. This lasted strong for 24 hours. I developed diarrhea with nausea and felt bad for a week.  I still have nausea even to this day. Then on 2/12/2022 I got a positive COVID-19 test. I had a feeling of a head cold. My daughter-in-law had COVID-19 so I got tested.
Age: 69.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Insomnia, Malaise, Mobility decreased, Nasopharyngitis, Nausea
Clinical narrative: The day of vaccine, my left arm was very sore and had a hard time sleeping. I could not lift my arm. I started to chill and finally went to sleep and woke up in a sweat. I woke up the next morning not feeling well. Then I went back to bed and felt feverish. My body had aches and pains. This lasted strong for 24 hours. I developed diarrhea with nausea and felt bad for a week.  I still have nausea even to this day. Then on 2/12/2022 I got a positive COVID-19 test. I had a feeling of a head cold. My daughter-in-law had COVID-19 so I got tested.
Age: 69.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Pain, Pain in extremity, Pyrexia, SARS-CoV-2 test negative, SARS-CoV-2 test positive
Clinical narrative: The day of vaccine, my left arm was very sore and had a hard time sleeping. I could not lift my arm. I started to chill and finally went to sleep and woke up in a sweat. I woke up the next morning not feeling well. Then I went back to bed and felt feverish. My body had aches and pains. This lasted strong for 24 hours. I developed diarrhea with nausea and felt bad for a week.  I still have nausea even to this day. Then on 2/12/2022 I got a positive COVID-19 test. I had a feeling of a head cold. My daughter-in-law had COVID-19 so I got tested.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Aspartate aminotransferase normal, Asthenia, Blood calcium increased, Blood chloride decreased, Blood glucose normal
Clinical narrative: NOCOVER> 1   HEALTH  SYSTEM LABORATORY Chart Review Copy                                                             (64 yrs) PT CLASS: Inpatient CSN:  DEPT:   PATIENT STATUS: Discharged GENDER: male BED:    ORD DR:    AUTH DR:    Results Covid-19, Flu, RSV by NAA     Contains abnormal data Covid-19, Flu, RSV by NAA Order:   Status: Final result    Visible to patient: No (inaccessible)    Next appt: 03/30/2022 at 09:15 AM in Radiology   Specimen Information: Nasopharyngeal; Swab    0 Result Notes    Component Ref Range & Units   Influenza A Not Detected Not Detected   Influenza B Not Detected Not Detected   RSV Not Detected Not Detected   SARS-CoV-2 (COVID-19) by NAA, Micro  Not Detected Detected Abnormal        Narrative   Methodology: Nucleic Acid Amplification(NAA)/Polymerase Chain Reaction(PCR)   The SARS-CoV-2 (COVID-19) test is for in vitro diagnostic use under the FDA Emergency Use Authorization (EUA) for laboratories certified under Agency to perform high complexity testing. This test has not been FDA cleared or approved.  Specimen Collected: 01/29/22  5:11 PM Last Resulted: 01/29/22  6:05 PM   Order Details    View Encounter    Lab and Collection Details    Routing
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Blood sodium decreased, Blood urea increased, COVID-19, Chemotherapy, Chest X-ray normal
Clinical narrative: NOCOVER> 1   HEALTH  SYSTEM LABORATORY Chart Review Copy                                                             (64 yrs) PT CLASS: Inpatient CSN:  DEPT:   PATIENT STATUS: Discharged GENDER: male BED:    ORD DR:    AUTH DR:    Results Covid-19, Flu, RSV by NAA     Contains abnormal data Covid-19, Flu, RSV by NAA Order:   Status: Final result    Visible to patient: No (inaccessible)    Next appt: 03/30/2022 at 09:15 AM in Radiology   Specimen Information: Nasopharyngeal; Swab    0 Result Notes    Component Ref Range & Units   Influenza A Not Detected Not Detected   Influenza B Not Detected Not Detected   RSV Not Detected Not Detected   SARS-CoV-2 (COVID-19) by NAA, Micro  Not Detected Detected Abnormal        Narrative   Methodology: Nucleic Acid Amplification(NAA)/Polymerase Chain Reaction(PCR)   The SARS-CoV-2 (COVID-19) test is for in vitro diagnostic use under the FDA Emergency Use Authorization (EUA) for laboratories certified under Agency to perform high complexity testing. This test has not been FDA cleared or approved.  Specimen Collected: 01/29/22  5:11 PM Last Resulted: 01/29/22  6:05 PM   Order Details    View Encounter    Lab and Collection Details    Routing
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Dizziness, Dyspnoea, Electrocardiogram normal
Clinical narrative: NOCOVER> 1   HEALTH  SYSTEM LABORATORY Chart Review Copy                                                             (64 yrs) PT CLASS: Inpatient CSN:  DEPT:   PATIENT STATUS: Discharged GENDER: male BED:    ORD DR:    AUTH DR:    Results Covid-19, Flu, RSV by NAA     Contains abnormal data Covid-19, Flu, RSV by NAA Order:   Status: Final result    Visible to patient: No (inaccessible)    Next appt: 03/30/2022 at 09:15 AM in Radiology   Specimen Information: Nasopharyngeal; Swab    0 Result Notes    Component Ref Range & Units   Influenza A Not Detected Not Detected   Influenza B Not Detected Not Detected   RSV Not Detected Not Detected   SARS-CoV-2 (COVID-19) by NAA, Micro  Not Detected Detected Abnormal        Narrative   Methodology: Nucleic Acid Amplification(NAA)/Polymerase Chain Reaction(PCR)   The SARS-CoV-2 (COVID-19) test is for in vitro diagnostic use under the FDA Emergency Use Authorization (EUA) for laboratories certified under Agency to perform high complexity testing. This test has not been FDA cleared or approved.  Specimen Collected: 01/29/22  5:11 PM Last Resulted: 01/29/22  6:05 PM   Order Details    View Encounter    Lab and Collection Details    Routing
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Haematocrit decreased, Haemoglobin decreased, Influenza A virus test negative, Influenza B virus test, Lymphocyte count decreased
Clinical narrative: NOCOVER> 1   HEALTH  SYSTEM LABORATORY Chart Review Copy                                                             (64 yrs) PT CLASS: Inpatient CSN:  DEPT:   PATIENT STATUS: Discharged GENDER: male BED:    ORD DR:    AUTH DR:    Results Covid-19, Flu, RSV by NAA     Contains abnormal data Covid-19, Flu, RSV by NAA Order:   Status: Final result    Visible to patient: No (inaccessible)    Next appt: 03/30/2022 at 09:15 AM in Radiology   Specimen Information: Nasopharyngeal; Swab    0 Result Notes    Component Ref Range & Units   Influenza A Not Detected Not Detected   Influenza B Not Detected Not Detected   RSV Not Detected Not Detected   SARS-CoV-2 (COVID-19) by NAA, Micro  Not Detected Detected Abnormal        Narrative   Methodology: Nucleic Acid Amplification(NAA)/Polymerase Chain Reaction(PCR)   The SARS-CoV-2 (COVID-19) test is for in vitro diagnostic use under the FDA Emergency Use Authorization (EUA) for laboratories certified under Agency to perform high complexity testing. This test has not been FDA cleared or approved.  Specimen Collected: 01/29/22  5:11 PM Last Resulted: 01/29/22  6:05 PM   Order Details    View Encounter    Lab and Collection Details    Routing
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Presyncope, Prothrombin time prolonged, Respiratory syncytial virus test negative, SARS-CoV-2 test positive
Clinical narrative: NOCOVER> 1   HEALTH  SYSTEM LABORATORY Chart Review Copy                                                             (64 yrs) PT CLASS: Inpatient CSN:  DEPT:   PATIENT STATUS: Discharged GENDER: male BED:    ORD DR:    AUTH DR:    Results Covid-19, Flu, RSV by NAA     Contains abnormal data Covid-19, Flu, RSV by NAA Order:   Status: Final result    Visible to patient: No (inaccessible)    Next appt: 03/30/2022 at 09:15 AM in Radiology   Specimen Information: Nasopharyngeal; Swab    0 Result Notes    Component Ref Range & Units   Influenza A Not Detected Not Detected   Influenza B Not Detected Not Detected   RSV Not Detected Not Detected   SARS-CoV-2 (COVID-19) by NAA, Micro  Not Detected Detected Abnormal        Narrative   Methodology: Nucleic Acid Amplification(NAA)/Polymerase Chain Reaction(PCR)   The SARS-CoV-2 (COVID-19) test is for in vitro diagnostic use under the FDA Emergency Use Authorization (EUA) for laboratories certified under Agency to perform high complexity testing. This test has not been FDA cleared or approved.  Specimen Collected: 01/29/22  5:11 PM Last Resulted: 01/29/22  6:05 PM   Order Details    View Encounter    Lab and Collection Details    Routing
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Squamous cell carcinoma, Throat cancer, Urine analysis, Urine ketone body present
Clinical narrative: NOCOVER> 1   HEALTH  SYSTEM LABORATORY Chart Review Copy                                                             (64 yrs) PT CLASS: Inpatient CSN:  DEPT:   PATIENT STATUS: Discharged GENDER: male BED:    ORD DR:    AUTH DR:    Results Covid-19, Flu, RSV by NAA     Contains abnormal data Covid-19, Flu, RSV by NAA Order:   Status: Final result    Visible to patient: No (inaccessible)    Next appt: 03/30/2022 at 09:15 AM in Radiology   Specimen Information: Nasopharyngeal; Swab    0 Result Notes    Component Ref Range & Units   Influenza A Not Detected Not Detected   Influenza B Not Detected Not Detected   RSV Not Detected Not Detected   SARS-CoV-2 (COVID-19) by NAA, Micro  Not Detected Detected Abnormal        Narrative   Methodology: Nucleic Acid Amplification(NAA)/Polymerase Chain Reaction(PCR)   The SARS-CoV-2 (COVID-19) test is for in vitro diagnostic use under the FDA Emergency Use Authorization (EUA) for laboratories certified under Agency to perform high complexity testing. This test has not been FDA cleared or approved.  Specimen Collected: 01/29/22  5:11 PM Last Resulted: 01/29/22  6:05 PM   Order Details    View Encounter    Lab and Collection Details    Routing
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Extra dose administered, SARS-CoV-2 test positive
Clinical narrative: Pfizer 1/5/21, 1/26/21, 2/26/21, 10/13/21; Positive on 3/9/22
Age: 42.0
Sex: F
Vaccine: MMR
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Patient wanted varivax, but I (pharmacist) administered MMR II. I called patient afterwards and told her of the error and patient was very understanding and said she was fine when I asked her how she was feeling. I then fixed the script on file to update to the correct vaccine given (varivax changed to MMR II).
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Lymphadenopathy, Peripheral swelling, Pyrexia
Clinical narrative: Starting the evening after receiving the vaccine, I developed swelling in my arm and it went numb from the shoulder to the end of my fingers. I had my annual physical scheduled for the next day, so I let the doctor know my symptoms. They let me know my lymph nodes were swollen underneath my arm into the left breast. They advised ice packs, and alternating ibuprofen and tylenol for the fever and the swelling of the lymph nodes. My temperature was elevated up to 102 for about 2 days after the vaccine. After about 3 days, the swelling of the lymph nodes went away.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Epstein-Barr virus infection, Epstein-Barr virus test positive, Fatigue, Hypoaesthesia, Limb discomfort
Clinical narrative: Parathesia in arms and hands, feet numb,heaviness in arms and legs, extreme fatigue
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Parathesia in arms and hands, feet numb,heaviness in arms and legs, extreme fatigue
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: COVID-19 resulting in inpatient hospitalization" of a vaccinated patient